In a large clinical trial the new oral anticoagulant #apixaban - TopicsExpress



          

In a large clinical trial the new oral anticoagulant #apixaban (Eliquis, Pfizer and Bristol-Myers Squibb) was at least as effective as standard therapy and caused fewer bleeding complications in patients with acute venous #thromboembolism. The results of the #AMPLIFY (Apixaban for the Initial Management of Pulmonary Embolism and Deep-Vein Thrombosis as First-Line Therapy) trial are being presented on Monday at the annual meeting of the International Society on Thrombosis and Haemostasis in Amsterdam and are being published in the New England Journal of Medicine.
Posted on: Mon, 01 Jul 2013 02:54:52 +0000

Trending Topics



Recently Viewed Topics




© 2015